Search News Archives
Special Offers and Promotions
Conferences | Events
IDEXX Acquires Tecta-PDS to Expand Water Microbiology Testing Capabilities
IDEXX, the global leader in rapid microbiology testing for water, has acquired Tecta-PDS, an innovative Canadian company that has introduced automation to water microbiology testing for parameters including E. coli and total coliforms. The acquisition allows IDEXX to expand its range of water microbiology testing options for both laboratory-based and in-field testing.
Founded in 2003, Tecta-PDS has developed an effective and reliable automated water testing solution and has grown to expand its customer base in more than 50 countries. The Tecta B16 and B4 instruments automate important steps in water microbiology testing, allowing results to be delivered to laboratories in real-time. Full automation of incubation and test interpretation eliminates the need for a visual read of the test. Results are sent anytime, anywhere by email with positive results available within hours. The Tecta method is U.S. EPA approved for detecting total coliforms and E. coli in drinking water.
“Tecta-PDS offers an innovative automated microbiology testing platform that advances the provision of safe and clean water worldwide,” said Chun-Ming Chen, Vice President and General Manager of IDEXX Water and OPTI Medical Systems. “We admire the ingenuity and customer satisfaction track record that Tecta-PDS has cultivated over the course of nearly twenty years. We look forward to introducing this platform to water testing laboratories globally and welcoming Tecta-PDS to IDEXX.”
IDEXX water testing solutions are approved or accepted by regulatory agencies in over 40 countries, protecting billions of people daily, delivering easy, rapid, accurate and cost-effective information on water quality to laboratories, public utilities, and facility managers. In addition to Tecta, IDEXX products include Colilert®-18 (ISO 9308-2) for 18-hour detection of coliforms and E. coli in water, Pseudalert® (ISO 16266-2) for 24-hour detection of Pseudomonas aeruginosa in facilities, hospitals, pools and spas, and Legiolert®, which detects Legionella pneumophila in 7 days.